O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 8.5 GBX Market Closed
Market Cap: 34.3m GBX
Have any thoughts about
Ondine Biomedical Inc?
Write Note

Net Margin
Ondine Biomedical Inc

-873.6%
Current
-2 616%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-873.6%
=
Net Income
-14.3m
/
Revenue
1.6m

Net Margin Across Competitors

Country CA
Market Cap 34.9m GBP
Net Margin
-874%
Country US
Market Cap 199.4B USD
Net Margin
14%
Country US
Market Cap 190.4B USD
Net Margin
29%
Country US
Market Cap 139.9B USD
Net Margin
16%
Country US
Market Cap 133.6B USD
Net Margin
11%
Country IE
Market Cap 103.6B USD
Net Margin
13%
Country US
Market Cap 66B USD
Net Margin
9%
Country DE
Market Cap 58.2B EUR
Net Margin
8%
Country US
Market Cap 44.6B USD
Net Margin
74%
Country CN
Market Cap 313.1B CNY
Net Margin
33%
Country US
Market Cap 36.2B USD
Net Margin
9%
No Stocks Found

Ondine Biomedical Inc
Glance View

Market Cap
34.3m GBX
Industry
Health Care

Ondine Biomedical, Inc. operates as a life sciences company that develops photodisinfection-based therapies to address drug-resistant infections. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-12-06. The firm is focused on developing products that utilizes its light-activated technology, primarily for the healthcare-associated infection (HAI) market. Photodisinfection provides a spectrum of antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. The company offers solution in Steriwave Nasal Decolonization (ND) and SurgENT. Steriwave ND provides a spectrum antimicrobial providing targeted decolonization. SurgENT is a tool for cleaning and irrigating the paranasal sinuses. The intrasinus balloon design directs irrigant circumferentially around the sinus walls, maintaining debridement pressure.

OBI Intrinsic Value
4.22 GBX
Overvaluation 50%
Intrinsic Value
Price
O

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-873.6%
=
Net Income
-14.3m
/
Revenue
1.6m
What is the Net Margin of Ondine Biomedical Inc?

Based on Ondine Biomedical Inc's most recent financial statements, the company has Net Margin of -873.6%.